Cas:112362-50-2 Dalfopristin manufacturer & supplier

We serve Chemical Name:Dalfopristin CAS:112362-50-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Dalfopristin

Chemical Name:Dalfopristin
CAS.NO:112362-50-2
Synonyms:Dalfopristin
Molecular Formula:C34H50N4O9S
Molecular Weight:690.84700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:940.5ºC at 760 mmHg
Density:1.27g/cm3
Index of Refraction:1.575
PSA:184.80000
Exact Mass:690.33000
LogP:3.61680

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Dalfopristin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Dalfopristin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dalfopristin Use and application,Dalfopristin technical grade,usp/ep/jp grade.


Related News: Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said. D-Glucitol, 1-deoxy-1-[2-[1-oxo-4-(1-pyrenyl)butyl]hydrazino]- manufacturers A thorough safety and risk analysis procedure should be administered at an appropriate time with documentation that adheres to the rules and regulations set forth by the regulatory authorities. 4-hydroxy-3,5-dimethylcyclohexa-3,5-diene-1,2-dione suppliers CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. 1-(2,2-Dimethyl-1-trimethylsilanyl-1-trimethylsilanyloxy-propyl)-4-trimethylsilanyl-benzene vendor & factory Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said.,A thorough safety and risk analysis procedure should be administered at an appropriate time with documentation that adheres to the rules and regulations set forth by the regulatory authorities.